Titan Spine Study Supports its Device Surface Technology
Titan Spine has a new study backing its device surface technology compared with PEEK and smooth titanium alloy materials. Researchers found a 100 percent increase in production of key angiogenic factors from osteoblast cells cultured on the Titan Spine surface versus PEEK.
The study will be published in the next issue of The Spine Journal.
More Articles on Supply Chain:
Medical Device Company DFINE Names Greg Barrett as President, CEO
NuVasive Spine Foundation Raises $230k for Improving Care of Global Patients in Need
Aurora Spine Completes IPO, Earns $3.61M for Lumbar Fusion Device Development
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.